DIVI S LABORATORIES LTD vs GAUDIUM IVF N WOMEN H L

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

DIVI S LABORATORIES LTD and GAUDIUM IVF N WOMEN H L are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
42.79
10.72
P/B ratio
5.62
0.44%
Dividend yield
0.00%
₹96.73
EPS
₹3.36

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
24.70%
22.00%
Return on capital
29.00%
33.00%
EBITDA margin
36.00%
24.32%
Net margin
23.08%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
33.21%
12.10%
Profit CAGR (3Y)
19.68%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹1,034 Cr
₹10,560 Cr
Revenue
₹104 Cr
₹2,568 Cr
Net profit
₹24 Cr
0.00
Debt / equity
0.16
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
GAUDIUM IVF N WOMEN H L
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 187 days.", "Working capital days have increased from 39.9 days to 90.9 days"]
DIVI S LABORATORIES LTD full analysis GAUDIUM IVF N WOMEN H L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.